Alexion Reports Third Quarter 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/6/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Alexion Pharma (ALXN) Tops Q3 EPS by 66c, Updates FY Guidance
October 29, 2020 6:33 AM EDTAlexion Pharma (NASDAQ: ALXN) reported Q3 EPS of $3.24, $0.66 better than the analyst estimate of $2.58. Revenue for the quarter came in at $1.59 billion versus the consensus estimate of $1.42 billion.
GUIDANCE:
Alexion Pharma sees FY2020 EPS of $11.70-$12.00, versus the consensus of... More
